Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Validation of Peptest™ in Patients with Gastro-Esophageal Reflux Disease and Laryngopharyngeal Reflux Undergoing Impedance Testing.

Bor S, Capanoglu D, Vardar R, Woodcock AD, Fisher J, Dettmar PW.

J Gastrointestin Liver Dis. 2019 Dec 9;28(4):383-387. doi: 10.15403/jgld-335.

2.

Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders.

Wang YJ, Lang XQ, Wu D, He YQ, Lan CH, Xiao X, Wang B, Zou DW, Wu JM, Zhao YB, Dettmar PW, Chen DF, Yang M.

J Neurogastroenterol Motil. 2020 Jan 30;26(1):74-84. doi: 10.5056/jnm19032.

3.

Alginates: From the ocean to gastroesophageal reflux disease treatment.

Bor S, Kalkan İH, Çelebi A, Dinçer D, Akyüz F, Dettmar P, Özen H.

Turk J Gastroenterol. 2019 Sep;30(Suppl2):109-136. doi: 10.5152/tjg.2019.19677. No abstract available.

4.

Validation in China of a non-invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease.

Wang YF, Yang CQ, Chen YX, Cao AP, Yu XF, Yu Y, Zhang ZY, Shen XZ, Liu F, Zhong L, Wang YX, Liu ZJ, Shi YH, Zhong J, Li JN, Lan Y, Lenham RK, Woodcock AD, Dettmar PW, Fang JY.

J Dig Dis. 2019 Jun;20(6):278-287. doi: 10.1111/1751-2980.12783.

5.

Letter: studies of salivary pepsin in patients with gastro-oesophageal reflux disease.

Dettmar PW, Woodcock AD, Wilcox MD, Chater PI, Pearson JP.

Aliment Pharmacol Ther. 2019 May;49(9):1248-1249. doi: 10.1111/apt.15213. No abstract available.

6.

Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration.

Johnston N, Dettmar PW, Ondrey FG, Nanchal R, Lee SH, Bock JM.

Ann N Y Acad Sci. 2018 Dec;1434(1):282-289. doi: 10.1111/nyas.13729. Epub 2018 May 17. Review.

PMID:
29774546
7.

A comparative study on the raft chemical properties of various alginate antacid raft-forming products.

Dettmar PW, Gil-Gonzalez D, Fisher J, Flint L, Rainforth D, Moreno-Herrera A, Potts M.

Drug Dev Ind Pharm. 2018 Jan;44(1):30-39. doi: 10.1080/03639045.2017.1371737. Epub 2017 Sep 13.

PMID:
28836872
8.

Association of Gel-Forming Mucins and Aquaporin Gene Expression With Hearing Loss, Effusion Viscosity, and Inflammation in Otitis Media With Effusion.

Samuels TL, Yan JC, Khampang P, Dettmar PW, MacKinnon A, Hong W, Johnston N, Papsin BC, Chun RH, McCormick ME, Kerschner JE.

JAMA Otolaryngol Head Neck Surg. 2017 Aug 1;143(8):810-817. doi: 10.1001/jamaoto.2017.0386.

9.

Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.

Zeybel GL, Pearson JP, Krishnan A, Bourke SJ, Doe S, Anderson A, Faruqi S, Morice AH, Jones R, McDonnell M, Zeybel M, Dettmar PW, Brodlie M, Ward C.

J Cyst Fibros. 2017 Jan;16(1):124-131. doi: 10.1016/j.jcf.2016.07.004. Epub 2016 Jul 27.

10.

Detection of pepsin in sputum: a rapid and objective measure of airways reflux.

Strugala V, Woodcock AD, Dettmar PW, Faruqi S, Morice AH.

Eur Respir J. 2016 Jan;47(1):339-41. doi: 10.1183/13993003.00827-2015. Epub 2015 Nov 5. No abstract available.

11.

Use of pepsin detection to identify airways reflux in a range of pulmonary diseases.

Strugala V, Dettmar PW, Bittenglova R, Fremundova L, Peŝek M.

Clin Respir J. 2017 Sep;11(5):666-667. doi: 10.1111/crj.12395. Epub 2015 Oct 12. No abstract available.

PMID:
26404422
12.

Topical protection of human esophageal mucosal integrity.

Woodland P, Batista-Lima F, Lee C, Preston SL, Dettmar P, Sifrim D.

Am J Physiol Gastrointest Liver Physiol. 2015 Jun 15;308(12):G975-80. doi: 10.1152/ajpgi.00424.2014. Epub 2015 Apr 23.

13.

Laser therapy of a dermal nevus in the esthetic zone of the nasal tip: A case report and comprehensive literature review.

Angermair J, Dettmar P, Linsenmann R, Nolte D.

J Cosmet Laser Ther. 2015;17(6):296-300. doi: 10.3109/14764172.2015.1027229. Epub 2015 Apr 14. Review.

PMID:
25803680
14.

Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease.

Hayat JO, Gabieta-Somnez S, Yazaki E, Kang JY, Woodcock A, Dettmar P, Mabary J, Knowles CH, Sifrim D.

Gut. 2015 Mar;64(3):373-80. doi: 10.1136/gutjnl-2014-307049. Epub 2014 May 7.

PMID:
24812000
15.

Mucin gene expression in reflux laryngeal mucosa: histological and in situ hybridization observations.

Ali Mel-S, Bulmer DM, Dettmar PW, Pearson JP.

Int J Otolaryngol. 2014;2014:264075. doi: 10.1155/2014/264075. Epub 2014 Mar 24.

16.

The modulation of pancreatic lipase activity by alginates.

Wilcox MD, Brownlee IA, Richardson JC, Dettmar PW, Pearson JP.

Food Chem. 2014 Mar 1;146:479-84. doi: 10.1016/j.foodchem.2013.09.075. Epub 2013 Sep 20.

17.

Objective detection of esophagopharyngeal reflux in patients with hoarseness and endoscopic signs of laryngeal inflammation.

Hayat JO, Yazaki E, Moore AT, Hicklin L, Dettmar P, Kang JY, Sifrim D.

J Clin Gastroenterol. 2014 Apr;48(4):318-27. doi: 10.1097/MCG.0000000000000011.

PMID:
24172180
18.

Laryngopharyngeal reflux and GERD.

Johnston N, Dettmar PW, Strugala V, Allen JE, Chan WW.

Ann N Y Acad Sci. 2013 Oct;1300:71-79. doi: 10.1111/nyas.12237. Review.

PMID:
24117635
19.

Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.

Sweis R, Kaufman E, Anggiansah A, Wong T, Dettmar P, Fried M, Schwizer W, Avvari RK, Pal A, Fox M.

Aliment Pharmacol Ther. 2013 Jun;37(11):1093-102. doi: 10.1111/apt.12318. Epub 2013 Apr 18. Erratum in: Aliment Pharmacol Ther. 2013 Jul;38(2):211.

20.

Assessment and protection of esophageal mucosal integrity in patients with heartburn without esophagitis.

Woodland P, Lee C, Duraisamy Y, Farré R, Dettmar P, Sifrim D.

Am J Gastroenterol. 2013 Apr;108(4):535-43. doi: 10.1038/ajg.2012.469. Epub 2013 Jan 29. Erratum in: Am J Gastroenterol. 2013 Aug;108(8):1377. Duraysami, Yasotha [corrected to Duraisamy, Yasotha].

PMID:
23358463
21.

Evaluation of an Innovative Over-the-Counter Treatment for Symptoms of Reflux Disease: Quick-Dissolving Alginate Granules.

Strugala V, Dettmar PW, Thomas EC.

ISRN Pharm. 2012;2012:950162. doi: 10.5402/2012/950162. Epub 2012 Dec 23.

22.

Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy.

Strugala V, Bassin J, Swales VS, Lindow SW, Dettmar PW, Thomas EC.

ISRN Obstet Gynecol. 2012;2012:481870. doi: 10.5402/2012/481870. Epub 2012 Nov 4.

23.

Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease.

Saritas Yuksel E, Hong SK, Strugala V, Slaughter JC, Goutte M, Garrett CG, Dettmar PW, Vaezi MF.

Laryngoscope. 2012 Jun;122(6):1312-6. doi: 10.1002/lary.23252. Epub 2012 Mar 23.

PMID:
22447277
24.

Reflux revisited: advancing the role of pepsin.

Bardhan KD, Strugala V, Dettmar PW.

Int J Otolaryngol. 2012;2012:646901. doi: 10.1155/2012/646901. Epub 2011 Nov 10.

25.

Gastroesophageal reflux and idiopathic pulmonary fibrosis: a prospective study.

Fahim A, Dettmar PW, Morice AH, Hart SP.

Medicina (Kaunas). 2011;47(4):200-5.

26.

Diet and lifestyle as trigger factors for the onset of heartburn.

Oliver K, Davies G, Dettmar P.

Nurs Stand. 2011 May 11-17;25(36):44-8.

PMID:
21702354
27.

A Randomized, controlled, crossover trial to investigate times to onset of the perception of soothing and cooling by over-the-counter heartburn treatments.

Strugala V, Dettmar PW, Sarratt K, Sykes J, Berry P, Thomas E.

J Int Med Res. 2010 Mar-Apr;38(2):449-57.

PMID:
20515559
28.

Laryngeal mucosa: its susceptibility to damage by acid and pepsin.

Bulmer DM, Ali MS, Brownlee IA, Dettmar PW, Pearson JP.

Laryngoscope. 2010 Apr;120(4):777-82. doi: 10.1002/lary.20665.

PMID:
20213655
29.

Physiological parameters governing the action of pancreatic lipase.

Brownlee IA, Forster DJ, Wilcox MD, Dettmar PW, Seal CJ, Pearson JP.

Nutr Res Rev. 2010 Jun;23(1):146-54. doi: 10.1017/S0954422410000028. Epub 2010 Mar 1. Review.

PMID:
20193096
30.

Bowel habit, diet and body weight in preadolescent children.

Jennings A, Davies GJ, Costarelli V, Dettmar PW.

J Hum Nutr Diet. 2010 Oct;23(5):511-9. doi: 10.1111/j.1365-277X.2009.01039.x. Epub 2010 Feb 15.

PMID:
20163508
31.

Micronutrient intakes of pre-adolescent children living in London.

Jennings A, Davies GJ, Costarelli V, Dettmar PW.

Int J Food Sci Nutr. 2010 Feb;61(1):68-77. doi: 10.3109/09637480903229009.

PMID:
19961352
32.

Alginate-antacid combinations: raft formation and gastric retention studies.

Hampson FC, Jolliffe IG, Bakhtyari A, Taylor G, Sykes J, Johnstone LM, Dettmar PW.

Drug Dev Ind Pharm. 2010 May;36(5):614-23. doi: 10.3109/03639040903388290.

PMID:
19925256
33.

The role of an alginate suspension on pepsin and bile acids - key aggressors in the gastric refluxate. Does this have implications for the treatment of gastro-oesophageal reflux disease?

Strugala V, Avis J, Jolliffe IG, Johnstone LM, Dettmar PW.

J Pharm Pharmacol. 2009 Aug;61(8):1021-8. doi: 10.1211/jpp/61.08.0005.

PMID:
19703345
34.

Body mass index and age affect Three-Factor Eating Questionnaire scores in male subjects.

Harden CJ, Corfe BM, Richardson JC, Dettmar PW, Paxman JR.

Nutr Res. 2009 Jun;29(6):379-82. doi: 10.1016/j.nutres.2009.04.001.

PMID:
19628103
35.

Dietary fibre, fluids and physical activity in relation to constipation symptoms in pre-adolescent children.

Jennings A, Davies GJ, Costarelli V, Dettmar PW.

J Child Health Care. 2009 Jun;13(2):116-27. doi: 10.1177/1367493509102469.

PMID:
19458167
36.

The online Cough Clinic: developing guideline-based diagnosis and advice.

Dettmar PW, Strugala V, Fathi H, Dettmar HJ, Wright C, Morice AH.

Eur Respir J. 2009 Oct;34(4):819-24. doi: 10.1183/09031936.00126908. Epub 2009 Mar 26.

37.

Prevalence of symptoms suggestive of extra-oesophageal reflux in a general practice population in the UK.

Lowden M, McGlashan JA, Steel A, Strugala V, Dettmar PW.

Logoped Phoniatr Vocol. 2009;34(1):32-5. doi: 10.1080/14015430902735847.

PMID:
19214865
38.

Habitual micronutrient intake during and after pregnancy in Caucasian Londoners.

Derbyshire E, Davies GJ, Costarelli V, Dettmar PW.

Matern Child Nutr. 2009 Jan;5(1):1-9. doi: 10.1111/j.1740-8709.2008.00152.x.

PMID:
19161540
39.

Alginate reduces the increased uptake of cholesterol and glucose in overweight male subjects: a pilot study.

Paxman JR, Richardson JC, Dettmar PW, Corfe BM.

Nutr Res. 2008 Aug;28(8):501-5. doi: 10.1016/j.nutres.2008.05.008.

PMID:
19083452
40.

Daily ingestion of alginate reduces energy intake in free-living subjects.

Paxman JR, Richardson JC, Dettmar PW, Corfe BM.

Appetite. 2008 Nov;51(3):713-9. doi: 10.1016/j.appet.2008.06.013. Epub 2008 Jul 4.

PMID:
18655817
41.

The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux.

McGlashan JA, Johnstone LM, Sykes J, Strugala V, Dettmar PW.

Eur Arch Otorhinolaryngol. 2009 Feb;266(2):243-51. doi: 10.1007/s00405-008-0708-7. Epub 2008 May 28.

PMID:
18506466
42.

Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.

Strugala V, Dettmar PW, Pearson JP.

Int J Clin Pract. 2008 May;62(5):762-9. doi: 10.1111/j.1742-1241.2007.01665.x. Epub 2008 Jan 8.

PMID:
18194279
43.

The suppression of gastro-oesophageal reflux by alginates.

Dettmar PW, Hampson FC, Taubel J, Lorch U, Johnstone LM, Sykes J, Berry PJ.

Int J Clin Pract. 2007 Oct;61(10):1654-62. Epub 2007 Aug 6.

PMID:
17681004
44.

Action of reactive oxygen species on colonic mucus secretions.

Brownlee IA, Knight J, Dettmar PW, Pearson JP.

Free Radic Biol Med. 2007 Sep 1;43(5):800-8. Epub 2007 May 23.

PMID:
17664143
45.

Association of heartburn during pregnancy with the risk of gastroesophageal reflux disease.

Bor S, Kitapcioglu G, Dettmar P, Baxter T.

Clin Gastroenterol Hepatol. 2007 Sep;5(9):1035-9. Epub 2007 Jul 19.

PMID:
17644491
46.

The effect of alginates on deoxycholic-acid-induced changes in oesophageal mucosal biology at pH 4.

Dettmar PW, Strugala V, Tselepis C.

J Biomater Sci Polym Ed. 2007;18(3):317-33. Erratum in: J Biomater Sci Polym Ed. 2007;18(7):939. Jankowski, Janusz A [removed].

PMID:
17471768
47.

Activity/stability of human pepsin: implications for reflux attributed laryngeal disease.

Johnston N, Dettmar PW, Bishwokarma B, Lively MO, Koufman JA.

Laryngoscope. 2007 Jun;117(6):1036-9.

PMID:
17417109
48.

Prepregnancy body mass index and dietary intake in the first trimester of pregnancy.

Derbyshire E, Davies J, Costarelli V, Dettmar P.

J Hum Nutr Diet. 2006 Aug;19(4):267-73.

PMID:
16911239
49.

Diet, physical inactivity and the prevalence of constipation throughout and after pregnancy.

Derbyshire E, Davies J, Costarelli V, Dettmar P.

Matern Child Nutr. 2006 Jul;2(3):127-34.

PMID:
16881925
50.

Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole.

Dettmar PW, Hampson FC, Jain A, Choubey S, Little SL, Baxter T.

Indian J Med Res. 2006 Apr;123(4):517-24.

PMID:
16783042

Supplemental Content

Loading ...
Support Center